| |
|
|
|
Tenax Therapeutics Inc.  
|
|
3.905 0.105 (0.03%) |
11-19 16:00 |
|
Open: |
3.98 |
Pre close: |
3.8 |
Target:
|
6.29
|
|
High: |
4.15 |
Low: |
3.905 |
Resistance:
|
5.38
6.39
|
|
Volume: |
8,315 |
Market Cap: |
6M |
Support:
|
3.75
3.12
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
3.87
 |
MACD |
MACD(12,26):
|
-0.32 |
|
MA(20): |
4.54 |
Signal(12,26,9): |
-0.24 |
|
MA(100): |
5.48 |
Stochastic Oscillator |
%K(14,3):
|
4.88  |
|
MA(250): |
6.43 |
%D(3): |
4.75 |
|
Average Volume(K) |
3-Month: |
874
|
52-Week |
High:
|
12.63 |
|
10-Days: |
1712 |
Low: |
3.75 |
|
RSI |
RSI(14):
|
34.24 |
Change(%): |
-52.5 |
|
Financials, Statistics and Valuation |
|
EPS |
0.000 |
Return on Equity (ttm) |
-64.3 |
Shares Out. (M) |
1.47 |
|
EPS Est. Current Year |
-0.360 |
Return on Assets (ttm) |
-55.0 |
Shares Float (M) |
0.00 |
|
EPS Est. Next Year |
-0.280 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
-0.080 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
3.90 |
|
Forward EPS |
-2.633 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
0.930 |
EBITDA (p.s.) |
0.000 |
P/E |
0.00 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
4.20 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-5.25 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-4.39 |
P/CF |
-1.09 |
|
|
|
|
|
|
